FindTrial
Sign In

Post operative dexmedetomidine nebulization for post operative pain management

Post operative dexmedetomidine nebulization as an analgesic adjunct in post operative pain management: A randomised controlled trial in laparoscopic cholecystectomy patients

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057764
Enrollment
120
Registered
2023-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K80- Cholelithiasis

Interventions

Intervention1: Post operative dexmedetomidine nebulization for pain management: Group A recieve dexmedetomidine nebulization at a concentration of 2 mcg/kg body weight, and monitored for 24 hours Cont

Sponsors

DEPARTMENT OF ANAESTHESIOLOGY, RAJENDRA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Physical status I and II. Weight of 45 to 90 kg. Height of 150 to 180 cms. Patients undergoing elective laparoscopic cholecystectomy surgery.

Exclusion criteria

Exclusion criteria: ASA Physical status III and IV. Patient unwilling. Haemodynamically unstable patients. Duration of surgery exceeding more than 2 hour. History of any allergy to general anaesthetic agents. Significant history of drug/alcohol abuse. Patients with comorbidities (hypertension, diabetes).

Design outcomes

Primary

MeasureTime frame
To compare the pain scores (NRS) in both group To compare the total dose of rescue analgesia used in both groups.Timepoint: To compare the pain scores (NRS) in both group within 24 hours, namely at 15 mins, 30 mins, 1 hr, 2 hr, 6 hr, 12 hr, 24 hr. To compare the total dose of rescue analgesia used in both groups, within 24 hours.—

Secondary

MeasureTime frame
Sedation score (Ramsay) in both the group Incidence of delirium in both the group Post operative sore throat in both the groupTimepoint: 24 hour—

Countries

India

Contacts

Public ContactDEEPAK HANSDAH

RAJENDRA INSTITUTE OF MEDICAL SCIENCES, RANCHI

dr.ladhulakra007@gmail.com9835160608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026